HIGHLIGHTS
- who: Abraham Nilsson and colleagues from the University Hospital Linkou0308ping, Linkou0308ping University, Linkou0308ping, Department of Orthopedics Eksjou0308 have published the research: A prophylactic subcutaneous dose of the anticoagulant tinzaparin does not influence qPCR-based assessment of circulating levels of miRNA in humans, in the Journal: PLOS ONE of 18/Oct/2022
- what: Because low-molecular-weight heparins (LMWH) are widely used in routine healthcare the authors aimed to investigate whether a prophylactic dose of the LMWH tinzaparin influences qPCR-based quantification of circulating miRNAs. The aim of this study was to investigate the effect of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.